26-27 June, 2026
The event is divided into 5 different sessions
The first session
will focus on the recent advancements in COPD and its comorbidities, and in particular the need to better characterize the different phenotypes included under the umbrella of the term COPD, novel therapies for COPD and the major cardiovascular risk in patients with COPD.
The second session
will focus on asthma as a disease of both central and peripheral airways, the need for integration of traditional pharmacological inhalation treatments with systemic agents and/or biologics, and ongoing research focused on mechanisms rather than clinical treatable traits.
The third session
will be devoted to the importance and impact of small airways dysfunction in chronic airway diseases, in particular the fundamental role of inhalers, but also their environmental impact, the complex impact of respiratory and non-respiratory components of chronic airway diseases, and last but not least, how AI can help us to understand the role of small airways dysfunction.
The fourth session
will be devoted to novel discoveries in the field of pathology of chronic airway diseases, particularly the importance of mucus plugs and mucociliary clearance.
The fifth session
will be devoted to bronchiectasis, which in the last 15 years has been discovered to represent not only a treatable trait of other chronic airway diseases but also an independent treatable disease.
Scientific Referees
Prof. Dario Olivieri
Professor of Respiratory Disease, University of Parma, Italy
Prof. Gaetano Caramori
Full Professor of Respiratory Disease, University of Parma, Italy
Venue
Where
Viale Piacenza, 12/c,
43100 Parma PR
When
Saturday to Sunday
June 26-27, 2026